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2Abbreviations
ACADVL: Acyl-CoA dehydrogenase very long chain, mitochondrial
AMPK: AMP-activated protein kinase
ANXA2: Annexin A2
ATP5A1: ATP synthase subunit alpha, mitochondrial
BP: Biological process
CC: Cellular component
CKM: Creatine kinase, muscle, cytoplasm
CKMT2: Creatine kinase, mitochondrial 2
CS: Citrate synthase
DDAH1: Dimethylarginine dimethylaminohydrolase
ESR1: Estrogen receptor alpha
FDR: False discovery rate
FETUB: Fetuin-B, cystein protease inhibitor family
GO: Gene ontology
GPD1: Glycerol-3-phosphate dehydrogenase 1, cytoplasmic
GSN: Gelsolin
HAD: Beta-hydroxy-Acyl-CoA dehydrogenase
HPRT1: Hypoxanthine phosphoribosyltransferase 1
KCNJ11: Potassium Channel, Inwardly Rectifying Subfamily J, Member 11
LDB3: LIM domain binding 3
LDH: Lactate dehydrogenase
LM: Longissimus muscle
LW: Large White
MACROD1: MACRO domain-containing protein 1
MF: Molecular function
MS: Meishan
MyHC: Myosin heavy chain
OXCT1: Succinyl-CoA:3-ketoacid-coenzyme A transferase 1, mitochondrial
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3PCIT: Partial correlation information theory
PCK2: Phosphoenolpyruvate carboxykinase 2, mitochondrial
PDIA3: Protein disulfide-isomerase A3
PPARGC1A: Peroxisome proliferator-activated receptor gamma coactivator 1-alpha
PSMC5: Proteasome 26S regulatory subunit
PYGM: Muscle glycogen phosphorylase
RF: Random forest
sCCA: Sparse canonical correspondance analysis
SEPT2: Septin 2
SIRT1: Sirtuin 1
sPLS: Sparse partial least square
sPLS-DA: Sparse partial least square - discriminant analysis
TNNT3: Troponin T type 3
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4Summary
Background. In pigs, the perinatal period is the most critical time for survival. Piglet maturation,
which occurs at the end of gestation, leads to a state of full development after birth. Maturity is thus an
important determinant of early survival. Skeletal muscle plays a key role in adaptation to extra-uterine
life, e.g. motor function and thermoregulation. Progeny from two breeds with extreme neonatal mortality
rates were analyzed at 90 and 110 days of gestation (dg). The Large White breed is a highly selected
breed for lean growth with a high rate of mortality at birth, whereas the Chinese Meishan breed is fatter
and more robust and has a low mortality rate. The aim of our study was to identify important molecular
signatures underlying late fetal muscle development of longissimus muscle.
Method. First, integrated analysis was used to explore relationships between co-expression network
models built from a proteomic dataset (bi-dimensional electrophoresis), and biological phenotypes of
interest. Second, possible correlations with a transcriptomic dataset (microarrays) were investigated to
combine different layers of expression with a focus on transcriptional regulation.
Results. Muscle glycogen content and myosin heavy chain polymorphisms were found to be good
descriptors of muscle maturity and were used for further data integration analysis. Using 113 protein spots
(89 identified unique proteins), network inference, correlation with biological phenotypes and functional
enrichment revealed that mitochondrial oxidative metabolism was a key determinant of neonatal muscle
maturity. Some proteins, including ATP5A1 and CKMT2, were identified as important nodes in the
network related to muscle metabolism. Transcriptomic data suggest that over-expression of mitochondrial
PCK2 was involved in the greater glycogen content of Meishan fetuses at 110 dg. GPD1, an enzyme
involved in the mitochondrial oxidation of cytosolic NADH, was also over-expressed in the Meishan
breed. Thirty-one proteins exhibited a positive correlation between their mRNA and protein levels,
suggesting transcriptional regulation in both extreme fetal genotypes. Gene ontology enrichment analysis
and Ingenuity analysis identified PPARGC1A and ESR1 as possible transcriptional factors positively
involved in late fetal metabolic maturation of skeletal muscle.
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5Introduction
One objective of systems biology is to investigate the regulation and interaction of various components
of the cell including DNA (genomics) [1], mRNA (transcriptomics) [2], proteins (proteomics) [3] or
metabolites (metabolomics) [4]. Even though transcriptomic analysis provides deep insights into cellular
processes, possible conclusions are limited [5]. Indeed, mRNA expression is not always a good predictor of
protein level because low correlations between mRNA and protein expression levels are often observed.
For example, a relatively small change in mRNA expression can result in a major change in the total
abundance of the corresponding protein, enabling potentially different conclusions to be drawn from
transcriptomic and proteomic analyses.
Biological integration of transcriptome and proteome remains challenging in omics studies due to the marked
differences between the two approaches, e.g. the dynamic range of regulation, incomplete annotation or
isoform differences [6]. The expression of genes may not be correlated with the abundance of proteins and
provide no information on post-transcriptional events, e.g. translational efficiency, alternative splicing,
folding or assembly into complexes [5, 7, 8]. An integrated multi-omics approach, with gene expression
experiments and large-scale protein identification experiments, should provide a deeper understanding of
the functional interactions between mRNA and protein layers as a complex biological system. Several
biological data integration strategies have already been suggested, see review by Ritchie et al. (2015) [9].
In this review, the authors suggested three meta-dimensional analyses combining multiple data types in
the same analysis: concatenation, transformation and model-based integration. Here we chose to develop
an innovative integration strategy combining state-of-the-art statistical and computational methods using
proteomic and phenotypic data, with the incorporation of transcriptomic information, to observe and
identify some important proteins with possible transcriptional regulation. One of the advantages of our
strategy is to avoid the scale issues that may arise when different types of data are combined.
Networks are increasingly used as tools for analysis and for the visualization of data in biology and
genetics [10–13]. A complex network architecture into clusters of functionally related genes/proteins can be
explored and genes/proteins with high connectivity (called hubs) can be identified. In our study, integrated
network analysis was first performed to explore relationships between co-expression network models,
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6built from a proteomic dataset, and phenotypes of interest that would enable identification of important
molecular signatures underlying late fetal muscle development. Correlations with a transcriptomic dataset
were then investigated to complete and combine different layers of expression.
Here we report the results of multi-omics analyses of muscle during the last three weeks of gestation in
pigs. The objective was to identify proteins, with possible transcriptional regulation, and related biological
mechanisms, specially those involved in differences in the muscle maturation process in late gestation
between two extreme pig breeds: Large White and Meishan, and reciprocal crosses. The Large White (LW)
breed is a highly selected breed for lean growth with a high rate of mortality at birth, whereas the Chinese
Meishan (MS) is a fatter and more robust breed that produces piglets with an extremely low mortality
rate [14, 15]. Physiological muscle maturity, which occurs at the end of gestation, has already been shown
to improve early survival after birth [16–18]. Successful maturation in late gestation thus likely leads to a
state of full development and promotes early survival after birth. Postnatal mortality due to immaturity is
not only an issue in pigs but affects other mammals including sheep [19] and humans [20, 21]. Adaptation
to extra-uterine life is therefore a major factor in the survival of all mammal species. In the present study,
using network data integration analysis, we identified key proteins involved in piglet maturity during late
gestation and provided an overview of the muscle maturation process in late gestation of which many
aspects can be generalized to other mammals.
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7Materials and Methods
Source data
Ethics statement
Use of animals and procedures performed in this study was approved by the European Union legislation
(directive 86/609/EEC) and French legislation in the Midi-Pyre´ne´es Region of France (Decree 2001-464
29/05/01; accreditation for animal housing C-35-275-32). The technical and scientific staff obtained
individual accreditation (MP/01/01/01/11) from the ethics committee (region Midi-Pyre´ne´es, France)
to experiment on living animals. All the fetuses used in this study were males and were obtained by
caesarean.
Study design
Details regarding animal resources and experimental designs can be found in [18]. Briefly, longissimus
skeletal muscle mRNA, protein and phenotypic data were acquired at two developmental time points (90
and 110 days of gestation (dg)) from four fetal genotypes. These genotypes consisted in two extreme
breeds concerning mortality at birth (Meishan (MS) and Large White (LW)) and two crosses (MSLW
from LW sows and LWMS from MS sows). MS and LW sows were inseminated with mixed semen so
that each litter was composed of purebred and crossbred fetuses. The two developmental time points
correspond to the end of gestation when intense maturation of muscle fibers occurs from 90 dg to birth
(around 114 dg) [16,17,22]. Therefore, eight conditions were considered according to the two development
time points and the four fetal genotypes (n = 64 fetuses exhibiting birth weight close to the average birth
weight within litter and genotype, nd90.MS = 8, nd90.LW = 8, nd90.MSLW = 8, nd90.LWMS = 8, nd110.MS =
8, nd110.LW = 10, nd110.MSLW = 6 and nd110.LWMS = 8).
Muscle sampling and biochemical analysis
The longissimus muscle (LM) was collected at the last rib level within 30 min after death, cut into small
pieces, snap frozen in liquid nitrogen, and stored at -75◦C until further analyses. Glycogen content was
determined in LM according to the method described by Good et al. [23] with minor adaptations [24], and
is expressed in g/100 g tissue wet weight. Myosin heavy chain (MyHC) polymorphism was characterized
both at the mRNA level by quantitative real-time PCR amplification using the TaqMan technology and
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8at the protein level using one dimensional sodium dodecyl sulfate-polyacrylamide gel electrophoresis (1D
SDS-PAGE) as previously described in [25]. At the mRNA level, the expression of each MyHC (MYH7 =
type I MyHC, MYH2 = type IIa MyHC, MYH1 = type IIx MyHC, MYH4 = type IIb MyHC, MYH3 =
embryonic MyHC, MYH8 = perinatal MyHC, MYH6 = α-cardiac MyHC and MYH13 = extraocular
MyHC) was calculated based on the PCR efficiencies and a calibrator, and expressed in comparison to an
invariant endogenous reference gene (hypoxanthine phosphoribosyltransferase 1, HPRT1 ) as described by
Pfaffl [26]. HPRT1 expression was not affected by the fixed factors used in the statistical analysis. Types
I, IIa, IIx and IIb MyHC are the four MyHC that define muscle fiber types in adult skeletal muscle [27],
whereas embryonic, perinatal, and α-cardiac MyHC are expressed transitorily during the fetal and early
postnatal periods in pigs [28,29]. At the protein level, four bands were separated by 1D SDS-PAGE and
corresponded to the embryonic, perinatal, fast-type II (IIa + IIx + IIb) and slow-type (I + α-cardiac)
MyHC, respectively [30]. Each band is expressed as a percentage of all four bands within a lane.
Proteome analysis
Muscle total protein extraction and bi-dimensional electrophoresis were performed on the 64 muscle
samples as previously described in [31]. Briefly, total proteins were extracted from 50 mg of powdered
frozen muscle tissue homogenized into 1 mL lysis buffer containing 7.5 M urea, 2 M thiourea, 2% CHAPS,
40 mM Tris base, 50 mM DTT, 1 mM EDTA, 1% IPG buffer pH 3-11 non-linear (NL), 1 µg/mL pepstatin
and 1.5 mg/mL complete protease inhibitor cocktail (Roche, Mannheim, Germany), using a handheld
Teflon-pestle-glass Potter-Elvehjem homogenizer. The lysate was incubated at room temperature for 1 h
with rotational shaking, followed by centrifugation at 60,000g for 1 h at 18◦C. Supernatant was collected
avoiding the fat layer, aliquoted and stored at -75◦C until further analysis. Protein concentration in the
supernatants was determined using the RC DC Protein Assay (Bio-Rad, Hercules, CA, USA) with bovine
serum albumin as a standard. For the first dimension, 300 µg protein were loaded onto immobilized
pH gradient strips (pH 3-11 NL, GE Healthcare, Uppsala, Sweden) and isoelectric focusing (IEF) was
performed using an Ettan IPGphorII system (GE Healthcare) at 20◦C up to a total of 88,600 Vh. At
the completion of IEF, equilibrated strips were transferred onto the top of a 12.5% uniform SDS-PAGE
gel using a vertical Ettan DALTsix system (GE Healthcare). After migration, gels were stained with
Coomassie Brilliant Blue G-250 (Bio-Rad). The gels were scanned using an UMAX ImageScanner (GE
Healthcare) and spot detection and quantification were performed by image analysis (Melanie 2D gene
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9analysis software V7.0; Swiss Institute of Bioinformatics, Lausanne, Switzerland). Artefacts and saturated
spots were removed from the analysis. Spots were matched across all 64 samples and 1,025 valid spots
were successfully matched between gels. For each gel, each spot volume was expressed as a percentage of
the volume of all matched spots on a given gel. Data were further log2 transformed. Representative 2D
electrophoresis gels are included in Additional file 1 and Additional file 2.
Experimental Design and Statistical Rationale
Protein identification is a really a posteriori time-consuming work. Statistics were done in a complete
blind manner and about 200 spots were expected for mass spectrometry identification. So that different
statistical methods were chosen to obtain a wide spectrum of protein expression including differential
analyses for depicting biological processes and discriminant analyses to identify possible markers. The
purpose of those methods was not the same. The analyses of variance were performed to get differentially
expressed spots according to the gestational time points and the fetal genotypes. Random forests and
sPLS-DA were used to find supplementary spots with a predictive power for gestational stages and/or
fetal genotypes. Finally, several statistical multivariate methods (sPLS and sCCA) were also performed to
find additional spots correlated with phenotypic biological characters of interest such as MyHC profiles.
These methods included analyses of variance to detect spots significantly affected by gestational time points
and fetal genotypes, in an additive or non-additive manner, as described in [18]. Briefly, to analyze jointly
differences between breeds and gestational ages, the following mixed linear model was first fitted to each
spot: Yijk = µ+Ai + FGj +A.FGij + Sk + ijk, with i ∈ {d90, d100}, j ∈ {LW,MS,LWMS,MSLW},
k = 1, ...18, Sk ∼ N (µ, σ2e) independent and identically distributed (iid) and ijk ∼ N (0, σ2e) iid. Sk
and ijk are mutually independent. Yijk is the expression of the spot being studied, µ a general mean
of the considered gene expression and ijk is a residual. This model includes two fixed effects and their
interaction: Ai is the effect of fetal gestational age i, FGj the effect of fetal genotype j and A.FGij the
interaction effect between gestational age i and genotype j. Sk represents the random sow effect. A
F-type test was achieved by comparing the complete model and the reduced model: Yijk = µ+ Sk + ijk.
A correction for multiple testing was then implemented using False Discovery Rate (FDR). The list of
Differentially Expressed Spots (DESs) was thereafter partitioned into 4 sub-models. Sub-model 1 combined
the two fixed effects and their interaction. Sub-model 2 involved the two fixed effects in an additive
manner. Sub-model 3 included only the fetal gestational age effect, whereas sub-model 4 contained only
9
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the fetal genotype effect. All models included the random sow effect. The Bayesian Information Criterion
(BIC) was used to associate each DES with one of these four sub-models. Only spots from sub-models 1
and 2 were kept for identification.
Secondly, random forest (RF) [32] and sparse partial least square discriminant analysis (sPLS-DA) [33])
were performed to find supplementary spots with a predictive power for gestational stages and/or fetal
genotypes. Several RFs analyses were conducted. We computed a classification RF according to the
experimental design and we also performed some regression RFs using phenotypes of interest (such as
embryonic or adult fast myosins). In each case, we selected spots with a high stability according to several
importance criteria (Gini and Accuracy indexes for the classification RF, Accuracy and the mean decrease
in MSE for regression RFs). We performed 20 RFs and kept the first fifteen spots according to those
importance criteria in order to evaluate the stability of the variable selection procedure. This allowed us
to assess how often a given spot, selected with our parameters/criteria, is selected when running several
RF procedures. In sPLS-DA, we chose to keep two axes and to keep 25 spots by axis. The first axis
discriminated the fetuses according to the gestational age, whereas the second one discriminated fetuses
according to the fetal genotype. No parameter was tuned using the mixOmics R functions because we
wanted to keep about 50 spots from this specific analysis and only two axes based on the PCA obtained
using the normalized proteome dataset.
Finally, several statistical multivariate methods (sparse partial least square (sPLS) [34] and sparse canonical
correlation analysis (sCCA) [35]) were also performed to find additional spots correlated with phenotypic
biological characters of interest such as MyHC profiles, plasmatic values and muscle glycogen content. In
sPLS analysis, 20 and 30 spots were kept according to axis 1 and 2, respectively. In sCCA, about 50 spots
were also kept to get as many spots as with sPLS analysis. Like in sPLS-DA, the first axis discriminated
the fetuses according to the gestational age and the second one according to the fetal genotype. In total,
179 spots were selected and manually excised from preparative gels loaded with 600 µg of proteins from
pooled samples for further identification by nano-LC-MS/MS, as described in [36].
An R script is provided as additional file in order to allow outside labs to reproduce all these anal-
yses (Additional File 3). Raw data that is used in the R script can be found in supplementary files
gel2D phenoData Voillet 2016.csv and gel2D Voillet 2016.csv.
Sequencing grade modified trypsin (Promega, ref. V511A) was used to generate peptides. In-gel tryptic
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digestion and protein identification by mass spectrometry were performed at the proteomic facilities in
Clermont-Ferrand (PFEMcp, INRA, Clermont-Ferrand Theix, France). Tryptic peptides were analyzed by
nano LC-MS/MS using nano-LC system Ultimate 3000TM RSLC (Dionex, Voisins le Bretonneux, France)
coupled on-line to an LTQ VELOS mass spectrometer (ThermoFisher Scientific, Courtaboeuf, France)
operated in a CID top 5 mode (i.e. one full scan MS and the five major peaks in the full scan were
selected for MS/MS). For database searches and protein identification, Thermo Proteome Discoverer 1.4
software was used with Mascot (Mascot server v2.2, http://www.matrixscience.com) to submit MS/MS
data to the SwissProt sequence database restricted to Sus scrofa (UniP Sus scrofa, 26127 sequences, June
6th, 2014 release). The following parameters were chosen for the searches: the mass tolerance for parent
and fragment ions was set to 1.5 Da and 0.5 Da, respectively, and a maximum of two missed cleavages was
allowed. Variable modifications were methionine oxidation (M) and carbamidomethylation (C) of cysteine.
Results were scored using the probability-based Mowse algorithm, where the protein score is -10*log(P)
and P is the probability that the observed match is a random event. Protein identifications were considered
valid if at least two peptides with a statistically significant Mascot score > 36 were assigned, and at least
20% sequence coverage was required. The accuracy of the experimental to theoretical isoelectric point
and molecular weight were also considered. Among the 179 selected spots, 120 spots, corresponding to 89
unique proteins, were successfully identified (Additional Files 4 and 5). Raw mass spectrometry data have
been deposited in the publicly accessible repository MassIVE site (ftp://MSV000081117@massive.ucsd.edu/
with id0181 as the password).
SDS-PAGE and immunoblotting
An aliquot of extracted proteins as used in the proteomic analysis was denatured in 1X Laemmli solution
(Sigma-Aldrich, St. Louis, MO, USA, ref S3401) at 95◦C during 5 min. Equal amounts of protein (30
µg per lane) were loaded onto 1.5 mm thick polyacrylamide gels (4 and 10% acrylamide in the stacking
and resolving gels, respectively) set on a Bio-Rad Mini-Protean tetra electrophoretic system as previously
described [37]. After migration in 1X running buffer (Bio-Rad, Marnes-la-Coquette, France, ref. 161-0772),
separated proteins were transferred overnight at 4◦C to polyvinylidene fluoride membranes at 30 V
using 1X transfer buffer (Bio-Rad, ref. 161-0771). Membranes were blocked for an hour in 1X TBS-T
with 5% blocking agent (Bio-Rad, ref 170-6404) at room temperature, and immunoblotted overnight at
4◦C with primary monoclonal antibody specific for CKMT2 (Abcam, Cambridge, MA, USA, ab131179,
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1:1,000 dilution). Blots were washed five times for 5 min with TBS-T before incubation for 1 h at room
temperature with the anti-mouse (from sheep) immunoglobulin G horseradish peroxidase conjugated
secondary antibody (GE Healthcare, Uppsala, Sweden, 1:5,000 dilution). Finally, the membranes were
washed with TBS-T, followed by development using an Enhanced Chemiluminescence Western blotting kit
(ECL-Prime, GE Healthcare). Images were scanned with an ImageQuant LAS 4000 (GE Healthcare) and
protein bands were quantified using the ImageQuant TL program. Membrane normalization was based
on a common sample repeated on every gel in three replicates and CKMT2 expression was expressed
as arbitrary units (AU) based on the ratio between CKMT2 signal of a given experimental sample and
CKMT2 signal of the common sample within the membrane. Beta-actin and tubulin could not be used
as normalizing factor because their expression was highly variable and influenced by the experimental
factors.
Metabolic enzyme activities
Activities of lactate dehydrogenase (LDH, E.C. 1.1.1.2.7), citrate synthase (CS, E.C. 1.1.3.7) and beta-
hydroxy-acyl-CoA dehydrogenase (HAD, E.C. 1.1.1.35) were used as markers of glycolytic metabolism,
global oxidative capacity (tricarboxylic cycle) and lipid beta-oxidation potential, respectively. Enzyme
activities were measured on LM as described previously [38] and expressed as micro-moles of substrate
degraded per minute per gram fresh muscle.
RNA preparation and gene expression data set
Total RNA was isolated from each of the 64 muscle samples as previously described in Voillet et al. [18].
After quality control and quantile normalization steps, 61 microarrays containing 44,368 probes were kept.
The raw and normalized data are available in the Gene Expression Omnibus under the accession number
GSE56301.
Integration of proteome network data
Network analysis was performed using a three step approach as illustrated in Figure 1 and at the two
developmental time points separately (90 and 110 dg (32 individuals per condition)), resulting in two
global networks. We chose to infer two networks to avoid the high gestational age effect already observed
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in a previous study analyzing a transcriptomic dataset with the same individuals [18]. All analyses were
performed using the R computing environment [39].
Figure 1 about here.
Inference of the proteome co-expression network
The first step consisted in inferring a proteome co-expression network using the PCIT (partial correlation
and information theory) algorithm [40] (Figure 1A). PCIT has already been successfully used in tran-
scriptomic analyses [41, 42]. In the present study, we performed PCIT on a proteomic data set. PCIT
belongs to the family of weighted network algorithms and is based on the combination of the concept of
partial correlation coefficient and the information theory to identify meaningful associations. Briefly, the
co-expression arrangements for all triplets are compared, with all triplets being exhaustively explored.
PCIT estimates the correlation for each pair of proteins taking the presence of a third protein into account.
Significant correlations establish an edge in the reconstruction of the network. Even though PCIT is a
soft-thresholding method, the number of selected edges was also adjusted according to the network density
(around 5% for each network) to obtain readable networks. This first step of the analysis was performed
with the R package PCIT [43].
Proteome network clustering
The second step consisted in finding communities within networks (Figure 1B). For each network, a spin-
glass model was performed to optimize the modularity Q [44] and to cluster nodes [45]. The modularity
Q is a measure of the quality of communities (or clusters) in a network: highly connected genes within
each community and weakly connected genes between communities [44]. As already described in [46], a
permutation test (100 permutations of edges corresponding to 100 random networks with the same degree
distribution) was used to declare whether or not the clustering was significant.
Proteome network community analysis and relationship with a phenotype of interest
The third step consisted in the biological analysis of each community (or sub-network). GeneMANIA
networks [47] were used to explore and confirm the relevance of the proposed communities. Gene ontology
(GO) enrichment analysis using the GeneCodis webservice [48] was used to identify the biological functions
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represented by each community (Figure 1C). For the significance of GO enrichment, multiple testing was
controlled using the false discovery rate (FDR) approach [49].
The third step included highlighting some nodes in each community. As already reported in other
studies [18,46], the betweenness of nodes within each community was analyzed (Figure 1C). A permutation
test with 1,000 permutations was performed to check if the betweenness centrality was significant with
respect to the node’s degree. A significant result (FDR < 0.05) indicated a node was more central in the
network than expected. Therefore, betweenness centrality is a good measure of the importance of the
node in the network. A node with a high betweenness (or centrality) value has a marked influence on the
structure of the network. All these analyses were performed using the R package igraph [50]. If no node
with significant betweenness was found, the nodes with the highest betweenness were highlighted.
In an integrative strategy, phenotypic information was also added to the co-expression network. Links
between sub-networks and biological phenotypes of interest were investigated (Figure 1C). To this end,
methods coming from spatial statistics were used as described in [13,51]. First, the correlation between
each protein expression community and the phenotype of interest was calculated. Second, a Moran’s I
was calculated to measure the spatial correlation between the sub-network structure and the phenotype
of interest. Then, to check if the correlation between the biological phenotype and the sub-network was
significant (p < 0.05), a permutation test with 1,000 node permutations was computed.
Network layout
All the graphs were laid out using the Force Atlas layout [52]. The degree (the number of adjacent edges)
is indicated by the size of the node, and betweenness is indicated by the color of the node. The colors of
the edges show whether the correlation between nodes is positive (in red) or negative (in blue). All these
analyses were performed using Gephi software [53].
Gene-protein integration
Among the 89 unique proteins identified, 81 corresponding genes were available in the muscle transcriptome
dataset [18]. When multiple probes mapped to the same gene, the highest differentially expressed
probe according to the interaction between gestational time points and fetal genotypes was retained.
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Transcriptomic and proteomic analyses were carried out using the same 64 muscle samples, but 60 fetuses
were available in both proteomic and transcriptomic datasets.
To identify proteins with possible transcriptional regulation, for each protein within each fetal genotype, a
Pearson’s correlation was computed between mRNA (from the gene expression dataset [18]) and protein
expression levels. A test was also run to assess if the correlation was significantly non-null (p < 0.01).
Multiple testing was controlled using the FDR approach [49].
From a biological point of view, the Ingenuity Pathway Analysis (IPA, QIAGEN Redwood City,
www.qiagen.com/ingenuity) software was used to check enrichment analysis (biological functions and
canonical pathways), to construct bibliographic networks and regulation networks based on the iden-
tification of potential upstream regulators. A focus was on sub-network 2 at 110 dg, because of its
relevant spatial correlation with two biological phenotypes of interest and a high number of proteins with
a possible transcriptional regulation. Briefly, IPA constructed two separated networks. The first was
based on bibliographic data in which the edges were obtained from biological links such as receptor-ligand
interactions, enzyme activity on another protein, or a transcriptional factor activating the expression of
targeted genes. IPA proposed the most probable network with an associated score. IPA also identified
upstream regulators with a statistical likelihood of targeting some of the genes or proteins in the network.
Finally, IPA generated a regulated network with the latest information. The proposed network (described
in the Results section) was reconstructed from both IPA networks by integrating direct and regulated
links. The PathDesigner function of IPA was used to draw a final graph with all previous information
plus the information related to the correlation between transcripts and proteins when the information was
available from the transcriptomic data.
15
16
Results
Analysis of MyHC polymorphism and muscle glycogen content
MyHC mRNA and protein levels and muscle glycogen content are listed in Table 1. All these biological
phenotypes were differentially expressed according to the interaction between the two developmental time
points (90 and 110 dg) and the four fetal genotypes (MS, LW, MSLW and LWMS), except slow (I +
α-cardiac) MyHC at the protein level. The expression of IIb and extra-ocular MyHC were undetectable
at 90 and 110 dg. In all four genotypes, embryonic and perinatal MyHC (mRNA and protein levels)
decreased at the end of gestation, whereas fast (IIa + IIx) and slow (I + α-cardiac) MyHC increased
during the maturation process. Embryonic MyHC was more highly expressed in LW than in MS fetuses
at 90 dg, whereas a higher value of fast (IIa and IIx) MyHC was observed in MS than in LW at 110 dg. A
high correlation between mRNA and protein levels was found for both embryonic and adult fast MyHC
(Pearson’s correlation between mRNA and protein levels equal to 0.95 and 0.93, respectively) (Figure 2).
Table 1 about here.
The profile of muscle glycogen content resembled that of adult fast MyHC between 90 and 110 dg with
a 2.6 fold increase during the maturation process (Table 1). At 90 dg, MS and LWMS fetuses already
exhibited higher muscle glycogen content than LW and MSLW fetuses. At 110 dg, levels reached 12.2%
in MS and LWMS vs 10.5% and 9.5% in MSLW and LW, respectively (p < 0.001). Figure 2 shows the
corresponding changes in muscle glycogen content and both embryonic and adult fast MyHC. Muscle
glycogen content was particularly well correlated with embryonic MyHC at 90 dg and with adult fast (IIa
+ IIx) MyHC at 110 dg.
Figure 2 about here.
Because MS piglets are known to be more mature than LW piglets at birth [15], embryonic MyHC, fast (IIa
and IIx) MyHC and muscle glycogen content are likely good descriptors of muscle physiological maturity
in pig neonates. These biological phenotypes were consequently used in the proteomic and transcriptomic
analyses to help identify proteins and genes potentially involved in the muscle maturation process in late
fetal stages.
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Proteomic analysis
Multiple statistical analyses to select potentially relevant protein spots
As described in Materials and Methods, several statistical methods were conducted to obtain a large
spectrum of proteins related to the experimental design. One hundred seventy nine spots were selected
among the 1,025 spots matched between gels. After protein identification, 120 spots, corresponding to 89
unique proteins, were successfully identified by LC-MS/MS and 18 proteins exhibited different isoforms.
To facilitate data interpretation and computation, protein isoforms were filtered to exclude redundant
isoforms (i.e. highly positively correlated isoforms). When multiple highly positively correlated isoforms
(Pearson’s correlation > 0.9) mapped to the same protein, only the most differentially expressed isoform
for the interaction between developmental time points and fetal genotypes was retained. Isoforms without
a high positive correlation were kept (Pearson’s correlation < 0.9). Finally, a total of 113 proteins were
retained and used for further analyses (Additional File 5).
The distribution of the 113 identified spots among the different statistical analyses is shown as a Venn
diagram in Figure 3. Seventy-one spots were significantly differentially expressed of which 13 were affected
by the interaction and 58 by the additive model between gestational time points and fetal genotypes. Using
RF and sPLS-DA analyses to obtain spots that distinguished gestational stages and/or fetal genotypes,
55 spots were selected. Then, 62 spots were also selected using several multivariate methods to obtain
spots correlated with the biological phenotypes of interest (MyHC polymorphism and glycogen content).
Altogether, a large number of spots overlapped between the multivariate and discriminant analyses, so
that 179 spots were finally selected.After spot identification by mass spectrometry and some isoform
removing, 113 proteins were identified.
Figure 3 about here.
The classification of the 113 identified proteins according to the biological axes is presented as a level plot in
Figure 4. Proteins involved in energy metabolism processes, such as glucose metabolism, gluconeogenesis,
oxidation-reduction activity and mitochondrion, were mostly over-expressed at 110 dg in all genotypes.
The figure also shows that oxidation-reduction related to mitochondria at 110 dg increased in the order LW
< MSLW < LWMS < MS. On the other hand, proteins involved in muscle development, such as system
development, actin skeleton, muscle filament sliding, cytoskeleton and mRNA metabolic process, were
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mostly over-expressed at 90 dg in all genotypes. All enriched biological functions and cellular components
are not shown in this figure, as we chose to highlight only important GO terms with a high number of
proteins. For that reason, some proteins do not belong to any of the biological processes shown.
Figure 4 about here.
Proteome sub-network analysis
Network inference was performed at each developmental time point according to the three-step inference
method presented in Figure 1. The largest connected component of the d90 and d110-proteome networks
are presented in Additional File 6 and characteristics of these networks (degree, betweenness and clustering)
are summarized in Additional Files 7 and 8, respectively.
d90-proteome network analysis
The largest connected component of the d90-proteome network was composed of 94 nodes and 314 edges
(density of 7.2%) and followed a scale-free topology denoting a non-random organization of the network [10].
After node clustering, five sub-networks were obtained (Table 2 and Figure 5A). All five sub-networks
displayed between 16-21 nodes and 26-55 edges. Additional File 9 displays all five sub-networks, and
Additional File 10 shows the enriched Gene Ontology (GO) terms for each sub-network. In several
sub-networks, some isoforms for the same protein were linked because only one developmental time point
was used for the network inference. Figure 5A shows that sub-networks 1, 2 and 4 had a high number
of edges in common, and shared a GO term corresponding to muscle filaments. Notably, these three
sub-networks were also those that were significantly and spatially correlated with the three biological
phenotypes of interest (Table 2). Figure 6 shows the three sub-networks (sub-networks 1, 2 and 4)
were significantly and spatially correlated with the biological phenotypes of interest. Sub-network 1 was
correlated with glycogen and embryonic MyHC, sub-network 2 to glycogen and adult fast (IIa + IIb +
IIx) MyHC, whereas sub-network 4 was only correlated with embryonic MyHC.
Table 2 about here.
Figure 5 about here.
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Figure 6 about here.
According to GO functional enrichment analysis, each sub-network was related to several biological
functions (Table 2): sub-network 1 was mainly involved in the myofibril (GO cellular component (CC)),
glycolysis (GO biological process (BP)) and mitochondrion (CC), sub-network 2 in actin filament (CC),
gluconeogenesis (BP) and mitochondrion (CC), and sub-network 4 in muscle filament sliding (BP),
gluconeogenesis (BP) and cell cycle checkpoint (BP). Sub-network 3 was mainly related to the respiratory
electron transport chain (BP), cell redox homeostasis (BP) and mitochondrion (CC), whereas sub-network
5 was related to the creatine metabolic process (BP) and sarcolemma (CC). It is important to note that
some identical GO terms were enriched in several sub-networks because a large number of the proteins
identified exhibited different isoforms and these isoforms could be present in different sub-networks. In
addition, the proteins we identified could also be involved in several metabolic functions.
To go deeper into the biological interpretation of the clusters, we chose to highlight the three sub-networks
correlated with the biological phenotypes of interest (Figure 6 and Table 2). Sub-network 1 showed a
significant correlation with muscle glycogen content and embryonic MyHC. The enriched GO biological
processes, such as glycolysis, glucose metabolic process and gluconeogenesis, were in agreement with the
glycogen correlation. FETUB (Fetuin-B, a member of the cysteine protease inhibitor family - involved
in the negative regulation of endopeptidase activity) and OXCT1 (Succinyl-CoA:3-ketoacid-coenzyme A
transferase 1, mitochondrial - involved in ketone body catabolic process) exhibited the highest degree of
this sub-network. In addition, FETUB exhibited the highest betweenness and was more highly expressed
in LW than in MS fetuses. Muscle filament sliding was also one of the enriched GO terms describing
this sub-network. In sub-network 2, one isoform (isoform 2) of PSMC5 (Proteasome 26S Regulatory
Subunit, ATP-dependent degradation of ubiquitinated proteins, 5) had significantly high betweenness
and the highest degree of this sub-network. This isoform of PSMC5 was more highly expressed in MS
than in LW fetuses (Figure 7). Three isoforms (isoforms 1, 2 and 4) of GPD1 (Glycerol-3-phosphate
dehydrogenase 1, cytoplasmic, involved in the glycerol phosphate shuttle) were also identified in this
sub-network. Interestingly, these three isoforms were more highly expressed in MS than in LW fetuses,
whereas GPD1 isoform 3 was less expressed in MS than in other genotypes (Figure 7). Muscle filament
sliding was also identified as a significant GO term to characterize sub-network 2. Sub-network 4 was
correlated with the embryonic MyHC. One isoform (isoform 2) of TNNT3 (Troponin T type 3) had
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significantly high betweenness and the highest degree of this sub-network. The enriched GO biological
processes, e.g. muscle filament sliding and development and cell cycle checkpoint, were in agreement with
the values of the phenotypic correlation. Two other TNNT3 isoforms (isoform 1 and 3) were also present
in this sub-network. It is noteworthy that a common GO term applied to sub-clusters 1, 2 and 4 related
to muscle filaments, which could denote a strong involvement of muscle filaments in the maturational
process at 90 dg, as previously highlighted on the level plot in Figure 4.
Figure 7 about here.
d110-proteome network analysis
The largest connected component of the d110-proteome network was composed of 86 nodes and 313 edges
(density of 8.6%) and had scale-free topology denoting a non-random organization as observed at 90 dg.
We obtained six clusters (Table 3 and Figure 5B). Additional File 11 shows all six sub-networks and
Additional File 12 shows the enriched GO terms for each sub-network. Among these six sub-networks, five
sub-networks displayed more than 10 nodes and 19 edges. Four sub-networks were spatially correlated
with muscle glycogen content (sub-networks 3, 4, 5 and 6), whereas three sub-networks were spatially
correlated with the embryonic MyHC (sub-networks 2, 3 and 4) or the adult fast MyHC (sub-networks 2,
3 and 5).
Table 3 about here.
GO term enrichment analysis was performed for each sub-network (Table 3): (i) sub-network 1 (only
five nodes) was involved in the tricarboxylic acid cycle (BP) and mitochondrion (CC), (ii) sub-network
2 consisted in 24 nodes and 65 edges and was primarily involved in the tricarboxylic acid cycle (BP),
respiratory electron transport chain (BP), glucose metabolic process (BP) and muscle filament sliding
(BP), (iii) sub-network 3 was involved in gluconeogenesis (BP) and glycolysis (BP), (iv) sub-network
4 in the mRNA metabolic process (BP) and in the proteasome complex (CC), (v) sub-network 5 in
muscle development (BP) and also lipid metabolism (BP), and (vi) sub-network 6 was mainly involved in
gluconeogenesis (BP), ATP catabolic/anabolic process activity (BP) and mitochondrion (CC).
As previously, we chose to highlight the five sub-networks correlated with a biological phenotype of
interest (Figure 10). Sub-network 2 was correlated with both adult fast and embryonic MyHC and had
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the highest number of nodes (24) and edges (65). This sub-network was primarily characterized by
GO terms corresponding to mitochondrial oxidative metabolism (Additional File 12). ATP5A1 (ATP
synthase subunit alpha, mitochondrial) showed significant high betweenness and CKMT2 (Creatine kinase,
mitochondrial 2) exhibited the highest degree of the sub-network. Both CKMT2 and ATP5A1 were more
highly expressed in MS than in LW fetuses (Figure 7). These proteomic results were validated for CKMT2
by western blotting carried out on the 64 fetuses (Figure 8). Briefly, CKMT2 increased dramatically
between 90 and 110 dg and was greater in MSMS fetuses at 110 dg, whereas MSLW and LWMS were
intermediate between LWLW and MSMS fetuses. This was also supported by enzyme activities with
a greater increase in activities of CS and HAD between 90 and 110 dg in MSMS fetuses (+283 and
+122% for CS and HAD, respectively) than in LWLW fetuses (+172% and +87%, respectively) (Figure 9).
Moreover, the differential increase between MSMS and LWLW fetuses was more important for CS than
HAD activities. Besides that, the activity of LDH did not differ between MSMS and LWLW fetuses
at 90 dg, remained stable in LWLW up to 110 dg and increased moderately (+31%) in MSMS fetuses
(Figure 9). Sub-network 3 was significantly correlated with all three phenotypes of interest and was
mainly involved in glucose metabolic process, gluconeogenesis and glycolysis occurring in the cytoplasmic
compartment. GSN (Gelsolin - involved in actin filament reorganization) was the protein with the
highest betweenness, but also the highest degree of this sub-network with PDIA3 also known as GRP58
(protein disulfide-isomerase A3 - involved in protein folding). Sub-network 4 was correlated with the
embryonic MyHC and muscle glycogen content and mostly involved in the proteasome complex and the
mRNA metabolic process. An isoform (isoform 1) of PSMC5 had the highest betweenness. This protein
and DDAH1 (Dimethylarginine dimethylaminohydrolase - involved in arginine metabolic process) had
the highest degree of this sub-network. Muscle glycogen content and adult fast MyHC were the two
biological phenotypes correlated with sub-network 5. PGAM1 (Phosphoglycerate Mutase 1 - involved in
the glycolytic process) was the protein with the highest degree, whereas one isoform (isoform 2) of LDB3
(LIM domain binding 3 - involved in sarcomere organization) had the highest betweenness. Sub-network
6 was significantly correlated with muscle glycogen content, which is consistent with the enriched GO
terms (e.g. gluconeogenesis and ATP catabolic/anabolic process). An isoform (isoform 2) of PSCM5
had the highest betweenness and the highest degree of this sub-network. Thus, PSMC5 isoform 2 had a
major influence on the structure of sub-network 6 at 110 dg and sub-network 2 at 90 dg, whereas PSCM5
isoform 1 played a key role in sub-network 4 at 110 dg. Two isoforms (isoform 2 and 4) of GPD1 were
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also present in sub-network 6 and under-expressed in LW fetuses (Figure 7).
Figure 8 about here.
Figure 9 about here.
Figure 10 about here.
Identification of mRNAs correlated with proteome networks
For each protein (with a corresponding gene in the transcriptomic dataset) within each extreme fetal
genotype, a Pearson’s correlation was computed between mRNA and protein expression levels in order
to identify proteins with possible transcriptional regulation. The transcriptomic dataset was previously
used in [18] and 60 fetuses were represented in both the transcriptomic and proteomic datasets. figure 11
shows the correlation between transcriptome and proteome in MS (x axis) and LW (y axis) genotypes.
Among the 81 proteins available in the transcriptomic dataset, 31 proteins exhibited a significant positive
correlation between mRNA and protein expression levels in both extreme fetal genotypes, 8 proteins
in LW only (mostly involved in muscle filament sliding and located in cytosol) and 13 proteins in MS
only (with no specific biological enrichment) (Figure 11 and Additional File 13). On the other hand,
one protein and its associated isoform (TNNT3 isoform 6) was also found to have a significant negative
correlation between mRNA and protein expression levels in both extreme genotypes, two proteins in LW
only (TNNT3 isoform 1 and LDB3 isoform 1) and two proteins (TNNT3 isoform 7 and GSN isoform 1) in
MS only (Additional File 13).
figure 11 about here.
For a more detailed biological interpretation, we chose to highlight the 31 proteins with a significant
positive correlation between mRNA and protein expression in both MS and LW pure fetuses. Sub-network
2 at 110 dg, already highlighted because of its relevant spatial correlation with two biological phenotypes of
interest (adult fast and embryonic MyHC), was particularly interesting. Thanks to the correlation analysis,
we showed that 10 nodes (seven belonging to the mitochondrion cellular component) among the 24 nodes
that comprised this sub-network exhibited a positive correlation between mRNA and protein expression
and were likely transcriptionally regulated (Additional File 13), especially CKMT2 and ATP5A1. An
IPA analysis of this sub-network (using all nodes) identified possible transcription factors (TFs) affecting
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these proteins, in particular PPARGC1A (peroxisome proliferator-activated receptor gamma coactivator
1-alpha) with an effect on CKM (creatine kinase, muscle, cytoplasm), ATP5A1, CKMT2 and ACADVL
(very long-chain specific acyl-CoA dehydrogenase, mitochondrial - involved in fatty acid beta-oxidation)
(Figure 12). The PPARGC1A gene (available in the transcriptomic dataset) was over-expressed at 110 dg
compared to 90 dg. It is interesting to note that at 90 dg, the expression of PPARGC1A was lower in LW
than in MS. This difference between genotypes, which was only visible at 90 dg, suggests that the increase
in PPARGC1A expression was delayed at 90 dg in LW, which could have subsequently reduced protein
expression of CKM, ATP5A1, CKMT2 and ACADVL at 110 dg in LW vs. MS fetuses. ESR1 (Estrogen
receptor alpha) was also seen to affect targets mostly involved in proliferation and differentiation of muscle
cells such as MACROD1 (MACRO Domain Containing 1), PDIA3 (isoform 2), SEPT2 (Septin 2), ANXA2
(Annexin A2) and GSN (Figure 12). The ESR1 gene (also available in the transcriptomic dataset) was
over-expressed at 110 dg with a higher expression in MS than in LW at both 90 and 110 dg. IPA identified
KCNJ11, a subunit of the ATP-sensitive K+ channel (KATP), as a regulator of many proteins involved in
energy metabolism that were up-regulated between 90 and 110 dg and over-expressed in MS compared to
LW at 110 dg. Expression of KCNJ11 at the mRNA level increased between 90 and 110 dg but did not
differ between genotypes. However, KCNJ11 is not a transcription factor but is involved in the regulation
of K+ ions in response to the ATP/ADP ratio [54] and cannot be considered as a potential upstream
transcriptional regulator of muscle maturity. Finally, IPA analysis identified several myogenic factors
whose expression decreased between 90 and 110 dg, and was lower in MS than in LW at 110 dg (see insert
in Figure 12), in accordance with better maturity of MS at birth.
figure 12 about here.
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Discussion
Embryonic MyHC, adult fast (IIa + IIx) MyHC and muscle glycogen content
are good descriptors of neonatal muscle maturity
In the present experiment, the adult fast IIa and IIx MyHC were already expressed before birth, whereas
no IIb was detected, which is in accordance with results obtained by [55]. In a previous study, we also
found that α-cardiac MyHC was transitorily expressed in pig skeletal muscle shortly after birth [29], and
the present results show that the α-cardiac MyHC is already expressed in late gestation. In all genotypes,
embryonic and perinatal MyHC (mRNA and protein levels) decreased at the end of gestation, whereas fast
(IIa + IIx) and slow (I + α-cardiac) MyHC increased during the maturation process. These results are in
agreement with those of a previous review [56] which exhaustively describes the ontogenesis of skeletal
muscle in farm species. In addition, because of a high correlation between mRNA and protein expression
(Figure 2), our results suggest transcriptional regulation of MyHC expression during the maturation
process. Lefaucheur et al. [57] already showed that expression of adult MyHC is very similar at the mRNA
and the protein levels in pig skeletal muscle at 60 kg body weight. This transcriptional regulation has also
been observed for other MyHC isoforms and is in accordance with previous results in skeletal muscle in
other species [58].
The maturation of skeletal muscle contractile and metabolic properties has been reported to influence
piglet maturity at birth [59, 60]. Among the MyHC phenotypes, embryonic and adult fast (IIa + IIx)
MyHC appear to be good markers of muscle maturity at 90 and 110 dg, respectively (Table 1). Indeed,
because embryonic MyHC was highly expressed at 90 dg but decreased drastically in late gestation, it is
likely a good marker of muscle immaturity at 90 dg (easily measurable because highly expressed) and its
higher expression in LW than MS points to a lower maturity of LW than MS fetuses at 90 dg. Conversely,
fast (IIa + IIx) MyHC was highly expressed at 110 dg and increased dramatically in late gestation, making
it a potentially good descriptor of muscle maturity around birth, and its higher expression in MS than
in LW fetuses points to higher maturity of MS than LW fetuses at 110 dg. Interestingly, the hybrid
fetuses were mostly intermediate between pure genotypes. In pigs, the adult fast IIa, IIx and IIb MyHC
progressively replace the developmental MyHC (embryonic and perinatal MyHC) in late gestation and
early after birth [56]. Because MS neonates are known to be more mature than LW, with a lower rate of
24
25
mortality at birth [15], the lower expression of embryonic MyHC at 90 dg and the higher expression of
adult fast (IIa and IIx) MyHC at 110 dg are representative of a better muscle maturity in MS than in LW
fetuses in late gestation, the hybrid fetuses being in an intermediate position.
In addition, good correspondence was found between the increased expression of adult fast (IIa + IIx)
MyHC and muscle glycogen content between 90 and 110 dg (Figure 2). Energy reserves, e.g. glycogen and
lipids, must be maximal in the neonatal period because piglets are not able to oxidize protein efficiently
before 5-7 days of life [59]. In pig neonates, muscle glycogen content is very high (about 9% of fresh muscle
vs. 1% in growing pigs [59]) and plays a key role in whole body glycogen storage (89% of total body
glycogen at birth [59]) and thermoregulation because neonatal pigs are devoid of brown adipose tissue and
only have a small amount of adipose tissue (about 1.5% of body weight). The animal’s energy requirement
is maximum in the neonatal period to promote locomotion, thermoregulation and growth. Therefore, a
high level of muscle glycogen at birth is likely involved in better neonatal maturity and piglet survival.
The higher muscle glycogen content found in MS fetuses in the present study is in agreement with the
better maturity previously reported in MS vs. LW neonates [15]. Interestingly, a difference between the
two extreme breeds in expression of genes involved in glycogen metabolic processes was already observed
during the same fetal period in the same individuals [18]. Thus, some genes were over-expressed at 110 dg
in MS only, such as PCK2 (phosphoenolpyruvate carboxykinase 2, mitochondrial also known as PEPCK
2) likely involved in gluconeogenesis from precursors derived from the citric acid cycle [18]. Therefore, the
significant difference we observed in muscle glycogen content between MS and LW can be, at least partly,
explained by these differences in the transcriptome. Interestingly, MS fetuses also exhibited a greater
PYGM (muscle glycogen phosphorylase) expression at the mRNA level than LW at 110 dg, which denotes
a higher capacity to use glycogen as an energy source in MS fetuses. Skeletal muscle appears to play a key
role in glycogen storage and oxidative metabolism around birth. We hypothesize that piglets with high
value for survival, like MS, have a higher ability to maintain glucose levels during and after farrowing,
and are more able to maintain body temperature.
Taken together, the present data showed that embryonic MyHC, adult fast (IIa + IIx) MyHC and muscle
glycogen content are good descriptors of muscle maturity in pig fetuses during late gestation, demonstrate
that MS fetuses are more mature than LW fetuses, and that hybrid fetuses are intermediate between
pure MS and LW breeds. All these three biological phenotypes were used in the further data integration
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analysis to help find new biological markers of neonatal maturity and to advance our understanding of
the underlying mechanisms.
Mitochondrial oxidative metabolism is a key determinant of neonatal muscle
maturity
Oxidative metabolism tends to increase during late gestation in all farm species making it an increasingly
important source of energy during fetal life [56]. To identify the biological processes underlying muscular
maturity, the GO terms classification was performed on the 89 unique identified proteins. A large number
of proteins associated with metabolic processes were identified. However, 2D gel electrophoresis is known
to reveal a limited collection of highly abundant and soluble proteins [61] covering a limited number of cell
functions, mainly dealing with cell structure and metabolism, which is why proteomic and transcriptomic
approaches are not always comparable [62].
Network analysis was performed and computed at the two developmental time points to identify proteins
with a relevant role in the network and to identify the biological processes. It is important to note that, at
both 90 and 110 dg, a large number of biological processes and cellular components overlapped between
sub-networks and, within each sub-network, the enriched biological analysis often highlighted a mixture of
GO terms. Indeed, it is sometimes difficult to assign a single biological function to a protein because they
often play several roles in interdependent metabolic pathways. Several isoforms were also found in the
proteomic dataset, and were diversely intercorrelated meaning two isoforms of the same protein could be
found in two different sub-networks.
The GO terms over-expressed at 90 dg were mostly involved in the actin cytoskeleton, muscle development
and mRNA processing (Figure 4). As already highlighted in a previous transcriptomic study using the
same individuals [18], these results are consistent with the second phase of myofiber genesis known to
occur between 55 and 90 dg in pigs [56]. The total number of muscle fibers increases up to approximately
90 dg and further muscle development mostly occurs through hypertrophy and maturation of existing
muscle fibers [56]. In addition, it has already been reported that the total number of myofibers is lower
in MS than LW [57] which helps explain the lower postnatal muscle growth capacity of MS than LW
pigs. Among the proteome sub-networks that were correlated with the biological phenotypes of interest
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(sub-networks 1, 2 and 4), all were characterized by GO terms involved in muscle filament development
and sliding, underlining the importance of filamentous proteins and likely of the cytoskeleton at this
stage. Notably, sub-network 2 also contained three isoforms of GPD1 (isoforms 1, 2 and 4) that were
over-expressed in MS fetuses (Figure 7). GPD1 is a cytoplasmic enzyme involved in the glycerol phosphate
shuttle that can transfer cytoplasmic glycolytic reducing NADH equivalents to mitochondrial FADH2 at
complex 2, thus providing ATP to the cell through the respiratory chain from complex 2 [63]. The higher
expression of these three GPD1 isoforms in MS at 90 dg could suggest increased mitochondrial oxidation
of cytosolic NADH in MS, which already contributes to the advanced maturity of MS fetuses. Surprisingly,
sub-networks 3 and 5, which were mostly involved in energy metabolism, had no significant correlation
with MyHC and muscle glycogen content at 90 dg. On the whole, our data suggest that muscle immaturity
at 90 dg is primarily related to the high proportion of cytoskeletal proteins and proteins involved in
myofibril assembly, even though some metabolic enzymes such as GPD1 could also be positively correlated
with the maturation process. In accordance with previous data in different farm species [56], a dramatic
increase in muscle oxidative metabolism occurred between 90 and 110 dg as shown by the proteomic,
western blotting and enzymatic data in the present experiment.
At 110 dg, the most striking differences between genotypes concerned the mitochondria cellular component,
in particular the mitochondrial oxidation/reduction molecular function (Figure 4). Moreover, the proteome
sub-network analysis identified gluconeogenesis and glycolysis as important co-expressed pathways that
could explain the higher muscle glycogen content in MS than in LW at 110 dg. Analysis of the proteome
sub-network identified five sub-networks that were correlated with the biological phenotypes of interest
(sub-networks 2, 3, 4, 5 and 6). Most were characterized by GO terms primarily involved in energy
metabolism (sub-networks 2, 3, 5 and 6), whereas GO terms dealt mostly with the proteasome complex
and mRNA processing in sub-network 4 with PSMC5 (isoform 1) as the most important node in the cluster.
The most relevant sub-network was sub-network 2 with 24 nodes and 65 edges. This sub-network was highly
correlated with adult fast and embryonic MyHC, and its GO terms primarily concerned mitochondrial
energy metabolism. Interestingly, CKMT2 and ATP5A1 were identified as important nodes in this cluster
which could be physiologically relevant for the production of energy such as ATP. Indeed, CKMT2 is a
creatine kinase and is responsible for the transfer of high energy phosphate from the mitochondria to
the cytosolic compartment, and at the same time for returning ADP to the respiratory system, thereby
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stimulating oxidative phosphorylation. Moreover, cytoplasmic muscle CKM was also over-expressed in
MS at 110 dg, suggesting that the energy metabolism of muscle contraction was higher in MS than
LW. ATP5A1 encodes a subunit of the mitochondrial ATP synthase that converts the mitochondrial
electrochemical H+ gradient to ATP production, thereby supplying ATP to the muscle. CKMT2 and
ATP5A1 are likely good biological markers of muscle maturity at 110 dg (Figure 7 and Figure 8). The
greater expression of CKMT2 and ATP5A1 in MS at 110 dg indicates that MS fetuses possess greater
oxidative capacity, which was supported by the greater activities of CS (tricarboxylic acid cycle) and
HAD (lipid beta-oxidation) enzymes (Figure 9), and in accordance with previous results showing greater
enzyme activities of CS and HAD in MS than LW muscle at birth [64]. Sub-network 3 was the second
most important cluster with 19 nodes and 46 edges. It was highly correlated with glycogen content as well
as embryonic and adult fast MyHC, and its GO terms mostly concerned glycolytic energy metabolism
and gluconeogenesis. Sub-network 6 was highly correlated with muscle glycogen content and logically, one
of its GO terms corresponded to gluconeogenesis. Moreover, two GPD1 isoforms (isoforms 2 and 4) were
also present in sub-network 6 and under-expressed in LW fetuses, as already observed at 90 dg (Figure 7).
Notably, expression of the four GPD1 isoforms was strongly influenced by the genotype with no effect of
age, and no interaction between genotype and development time points was observed (Additional File 5).
This suggests that GPD1 is genetically determined but not related to maturity as influenced by age. At
the mRNA level, as already demonstrated in [18], GPD1 gene expression was lower in LW than MS at 90
dg and did not increase in LW during the maturation process, whereas it did increase in MS. Therefore,
the gestational time point only had an effect on GPD1 at the mRNA level in MS. The greater GPD1
expression in MS than LW at 110 dg could be physiologically relevant through the transfer cytoplasmic
NADH to mitochondrial FADH2 (glycerol phosphate shuttle), which could contribute to the production of
energy through the oxidative phosphorylation in the respiratory chain. Interestingly, the mRNA expression
level of LDHA, which catalyzes the conversion of L-lactate and NAD to pyruvate and NADH in the final
step of anaerobic glycolysis was greater in MS than LW fetuses [18] and the decrease in blood lactate
concentration between the fetal vein and fetal artery was greater in MS than LW fetuses (-0.18 +/- 0.09
vs 0.05 +/- 0.20 mmol/L, respectively, P = 0.01), suggesting a greater use of lactate, mostly produced by
the placenta, as an energy source in MS than LW fetuses. The enzyme activity of LDH was significantly
greater in MSMS than LWLW fetuses (+17%, P = 0.04, Figure 9). However, LDH is a reversible enzyme
which can transform either pyruvate to lactate (+ NAD+) or lactate to pyruvate (+ NADH) depending
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on its isozymic composition and substrate availability, making it necessary to perform further work to
better understand the real metabolic fluxes through the LDH reaction. Because LDH activity dramatically
increases from birth to 15-20 days of age [65], the greater LDH activity in MSMS than LWLW fetuses at
110 dg could also be related to better maturity of MSMS piglets at birth. Altogether, the present data
show that muscle energy metabolism, in particular mitochondrial energy metabolism and muscle glycogen
storage, increased dramatically between 90 and 110 dg and were higher in MS than in LW fetuses at 110
dg, meaning that the mitochondrial oxidation/reduction process and glycogen storage, likely involving the
mitochondrial PEPCK (PCK2), play a crucial role in the late fetal muscle maturation process.
Biological data integration identified PPARGC1A as potential upstream tran-
scriptional regulator of muscle maturity at birth
To gain further insight into the molecular machinery underlying the muscle maturation process in pigs, we
undertook a guided and integrated analysis of the transcriptomic and proteomic datasets. Among the 89
unique proteins identified, 81 were available in the transcriptomic dataset. Using Pearson’s correlations,
mRNA and protein expression levels were analyzed to find proteins with possible transcriptional regulation.
Thirty-one proteins were identified with a significant positive correlation between mRNA and protein
expression levels in both extreme fetal genotypes (Pearson’s correlation |r| > 0.7) (Figure 11). A number
of transcriptome and proteome data integration studies have already been reported e.g. in cell lines [66–68],
plants [69], and mammal models [6, 70–73]. The correlation between mRNA and protein abundances
in the cell has been reported to be notoriously poor. At 110 dg, sub-network 2 was composed of 10
nodes (out of 24) with possible transcriptional regulation in both MS and LW. Proteins belonging to this
sub-network generally exhibited similar expression profiles at 110 dg, were mostly located in the same
cellular component and may possibly be regulated by common transcription factors (TFs). Based on a
bibliographic network computed using IPA software (using the upstream regulator function), we were
able to find possible upstream TFs. PPARGC1A was one of the TFs identified. It was a regulator of
CKMT2, ACADVL and ATP5A1 (Figure 12). CKMT2 has already been identified as an important node
(the highest betweenness for CKMT2 at 110 dg) and as a likely good biological marker of muscle maturity
at 110 dg.
PPARGC1A (also known as PGC1-alpha) is a transcriptional coactivator that controls the expression
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of many genes through a whole range of nuclear hormone receptors and other TFs [74]. Moreover, the
activity of PPARGC1A is regulated by phosphorylation and deacetylation through the coaction of two
upstream metabolic sensors of energy deficiency: AMPK and SIRT1, respectively [75]. PPARGC1A is
abundant in muscle [76] where it is involved in several biological functions such as mitochondrial biogenesis,
and oxidative metabolism, which play a key role in ATP production and the adaptation of muscle to
exercise and exposure to cold [77]. It has been shown to drive the formation of slow twitch fibers [78]
and to be more highly expressed in oxidative myofibers [75]. Therefore, together with AMPK and SIRT1,
PPARGC1A is involved in carbohydrate and lipid metabolisms to maintain energy homeostasis. In
post-natal growing pigs, PPARGC1A is more highly expressed in LM of Erhualian than LW pigs, in
accordance with a higher proportion of oxidative fibers in Erhualian pigs [79], as well as in MS pigs [57].
Voillet et al. [18] showed that PPARGC1A gene expression was differentially expressed depending on the
interaction between fetal genotypes and gestational time points, with higher expression in MS than LW at
90 dg. Therefore, our results suggest that PPARGC1A could have a precocious effect on the subsequent
greater increase in expression of genes such as CKMT2, ATP5A1, ACADVL and CKM in MS than LW
at 110 dg. Mitochondrial CKMT2 and cytoplasmic CKM are both involved in the creatine metabolic
process and are known to play a key role in the transfer of energy within the muscle fiber for muscle
contraction and thermogenesis. Interestingly, over-expression of PPARGC1A in the skeletal muscle of
transgenic mice has been shown to increase glycogen synthesis and storage [80], which could also explain
the greater glycogen content observed in MS compared to LW fetuses at 110 dg in the present experiment.
In addition, greater variability of PPARGC1A expression in LW than in MS was also observed at 110
dg. Therefore, PPARGC1A could be a relevant upstream regulator involved in the accelerated muscle
maturation observed in MS compared to LW in late gestation.
Cell culture experiments have shown that PPARGC1A is a coactivator of ESR1 [81]. Interestingly, ESR1
activation has also been reported to increase the expression of PPARGC1A, NRF1, IRS1 and GLUT4
in skeletal muscle of ovariectomized mice fed a high fat diet [82]. In our transcriptomic study, ESR1
expression increased dramatically between 90 and 110 dg and was greater in MS than LW fetuses at both
stages (Figure 12). In sub-network 2 at 110 dg, ESR1 was found to be a regulator of several proteins
mostly involved in protein folding (PDIA) and in cytoskeleton (SEPT2 and GSN). This estrogen receptor
has been reported to be involved in estrogen-mediated regulation of substrate metabolism [83] and lower
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mRNA expression has been observed in the adipose tissue of obese compared to lean women [84]. In ESR1
knock out mice, body weight was about 30% higher than in wild-type mice: mice were obese and their
oxidative metabolism was impaired [85]. In our study, under-expression of ESR1 in LW was accompanied
by reduced oxidative metabolism but not by increased fatness (LW leaner than MS). Altogether, ESR1
increased between 90 and 110 dg, and its over-expression in MS compared to LW could be involved, in
interaction with PPARGC1A, in the improved maturity of MS compared to LW animals at birth.
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Conclusion
In this study, we developed an innovative strategy combining state-of-the-art statistical and computational
methods to integrate multi-omics datasets to gain a deeper insight into the late fetal maturation process.
Three biological phenotypes of interest (i.e. adult fast and embryonic MyHC and muscle glycogen content)
were identified as good descriptors of maturity. Some proteins, involved in mitochondrial oxidative
metabolism and with a possible transcriptional regulation, were also emphasized as possible biomarkers
of the maturation process. As one of the main sources of energy during late fetal life, muscle oxidative
metabolism is very important at birth [56], and likely strongly influences muscle and whole body metabolic
maturity at the time of birth. In pigs, a higher rate of death at birth has already been observed in
genotypes with a lower percentage of oxidative fibers [15,57]. In recent decades, the pig industry has been
focusing on selection for rapid production of lean meat, low back-fat thickness and a rapid growth rate,
thus influencing muscle fiber properties [86]. More precisely, a selection for lean tissue is more associated
with muscles containing a low percentage of oxidative myofibers and a high percentage of large glycolytic
myofibers [87]. This kind of the selection could have an effect on important genes, such as PPARGC1A
and ESR1, with lower expression in skeletal muscle, which could contribute to an alteration or delay of
mitochondrial gene/protein expression in late gestation and lead to muscle metabolic immaturity at birth.
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Figure Legends
Figure 1: Overview of the network data integration analysis.
(A) Proteome networks were first inferred using the PCIT (partial correlation and information theory)
algorithm for each developmental time point: 90 days of gestation and 110 days of gestation. PCIT, which
belongs to the family of weighted network algorithms, is based on the combination of the concept of
partial correlation coefficient and the information theory to identify meaningful associations. (B) Network
clustering was then performed using a spin-glass algorithm. A permutation test was performed to assess
the significance of clustering. (C) Sub-networks (clusters) were analyzed. (i) GeneMANIA was used to
assess the relevance of the proposed sub-networks and GO enrichment analysis was performed to analyze
the biological functions of the sub-networks. (ii) Centrality (or betweenness) of nodes was analyzed using
a permutation test. (iii) Using spatial statistics tools, correlations between sub-networks and biological
phenotypes of interest were analyzed.
Figure 2: Co-variation of muscle glycogen and expression profiles (mRNA and proteins) of
myosin heavy chain (MyHC) genes (adult fast (IIa + IIb + IIx) and embryonic MyHC).
Lowess curves and confidence intervals are in blue and grey, respectively. Box-plots of mRNA or protein
expression and glycogen content are also shown. (A) mRNA embryonic MyHC. (B) Protein embryonic
MyHC. (C) mRNA adult Fast (IIa + IIb + IIx) MyHC. (D) Protein adult Fast (IIa + IIb + IIx) MyHC.
Figure 3: Global analysis of the 113 identified proteins.
Venn diagram of the statistical methods chosen to select spots for identification. 13 proteins (in blue)
were differentially expressed according to the interaction between developmental time points and fetal
genotypes. 58 proteins (in red) were differentially expressed in an additive manner between development
time points and fetal genotypes. 62 proteins (in green) were selected using sparse multivariate methods
(both sCCA and sPLS). 55 proteins (in yellow) were selected using discriminant analyses (both RF and
sPLS-DA). See the Materials and Methods section for further information.
Figure 4: Level plot of the 113 identified spots.
All spots were ranged according to the biological function. Muscle development functions and components,
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e.g. system development, actin skeleton, muscle filament sliding, cytoskeleton and mRNA metabolic
process, were mostly over-expressed at 90 dg. Energy metabolism functions and components, e.g. glucose
and gluconeogenesis metabolism, oxidation-reduction activity and mitochondrion, were mostly over-
expressed at the end of gestation (110 dg). All the biological functions and components are not included
in this figure.
Figure 5: Decomposition of the proteome networks.
(A) Each sub-network represents a cluster in the d90-proteome network. (B) Each sub-network represents
a cluster in the d110-proteome network. The width of the edge is proportional to the number of edges
between the two corresponding sub-networks.
Figure 6: Three sub-networks obtained at 90 days of gestation.
A PCIT model was used to infer a co-expression network. Nodes were clustered using a spin-glass model.
The figure shows three (out of five) sub-networks (1, 2 and 4) obtained by clustering. The color of the
nodes indicates betweenness centrality. The red nodes have the highest betweenness. The size of the
nodes indicates degree. The color of the edges indicates the correlation sign: red for positive correlations
and blue for negative ones.
Figure 7: Box plots of protein level expression.
PSMC5 with two isoforms, GPD1 with four isoforms, ATP5A1 and CKMT2.
Figure 8: Representative western blot gel (A) and box plot analysis (B) of CKMT2 expres-
sion in longissimus muscle (n = 64 fetuses).
M: molecular weight marker. Different letters between groups within fetal stages denote significant
differences (P < 0.05). ***: significant difference between fetal stages (P < 0.001).
Figure 9: Enzyme activities of lactate dehydrogenase (LDH), citrate synthase (CS) and
beta-hydroxy-Acyl-CoA dehydrogenase (HAD) in longissimus muscle of LWLW and MSMS
fetuses at 90 and 110 dg.
Activities are expressed as µmol of substrate degraded per minute per gram fresh muscle. Different letters
44
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denote significant differences (P < 0.05).
Figure 10: Five sub-networks obtained at 110 days of gestation.
A PCIT model was used to infer a co-expression network. Nodes were clustered using a spin-glass model.
This figure shows five (out of six) sub-networks (2, 3, 4, 5 and 6) obtained by clustering. The color of
the nodes indicates betweenness centrality. The red nodes have the highest betweenness. The size of the
nodes indicates degree. The color of the edges indicates the correlation sign: red for positive correlations
and blue for negative ones.
Figure 11: Correlation between transcriptome and proteome in both extreme fetal geno-
types (LW and MS).
Scatter plot of correlations between mRNA and protein expression levels in MS (x-axis) and LW (y-axis).
Each dot represents the correlation in MS and LW of a pair of gene-protein. Red dots show a significant
positive correlation in LW and MS, the green dots show a significant positive correlation only in MS, and
blue dots show a significant positive correlation only in LW. It is important to note that more than 81
points were represented because some proteins had several isoforms.
Figure 12: Bibliographic network obtained with the d110-sub-network 2. This network is
composed of 30 nodes. Ten nodes out of the 24 composing sub-network 2 were found to be possibly
transcriptionally regulated. Box plots of PPARGC1A, KCNJ11, MYOG and ESR1 mRNA expression
from [18] are also shown.
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